Extracellular Vesicle Research and Future Health Forum and EVCNA Board Meeting Conclude Successfully

From June 12 to 13, 2026, the Forum on Frontiers in Extracellular Vesicle Research and Future Health and the Editorial Board Meeting of Extracellular Vesicles and Circulating Nucleic Acids (EVCNA) were successfully held at Shanghai Jiao Tong University, Shanghai, China. The event was jointly organized by the Puyuan Institute for Future Technologies of Shanghai Jiao Tong University and EVCNA.

This forum focused on frontier areas in extracellular vesicle research, including basic biology, technological innovation, clinical translation, and future health applications. It brought together more than 100 experts, scholars, researchers, and industry representatives to discuss the latest advances and future trends in the field of extracellular vesicles. The conference featured 35 high-level academic presentations, including one academician lecture, five plenary presentations, 28 sub-forum presentations, and one roundtable discussion. The presentations covered the entire spectrum from fundamental mechanistic research to clinical translational applications, fully demonstrating the field's cutting-edge vitality and trend toward interdisciplinary integration in the field of extracellular vesicles.

Distinguished guests attending the conference included:

• Academician Chunhai Fan, Shanghai Jiao Tong University, Shanghai, China
• Professor Weiliang Xia, Shanghai Jiao Tong University, Shanghai, China
• Mr. Min Fan, President, OAE Publishing Inc.
• Professor Yoke Peng Loh, National Institutes of Health (NIH), Bethesda, Maryland, USA (online)
• Professor Yan Jin, Air Force Medical University, Xi'an, China
• Professor Min Zhou, Zhejiang University, Hangzhou, China
• Professor Tao Na, National Institutes for Food and Drug Control, Beijing, China
• Professor Jan Lötvall, University of Gothenburg, Gothenburg, Sweden
• Professor Chaohui Huang, Affiliated Hospital of Jiangnan University, Wuxi, China
• Professor Shenglin Huang, Institute of Biomedical Sciences and Affiliated Cancer Hospital of Fudan University, Shanghai, China
• Professor Hua Xiao, Shanghai Jiao Tong University, Shanghai, China
• Professor Jingping Liu, West China Hospital, Sichuan University, Chengdu, China
• Professor Hui Yu, Shanghai Jiao Tong University, Shanghai, China
• Professor Qingling Fu, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
• Professor Xunbin Wei, Peking University Advanced Institute of Clinical Medicine, Beijing, China
• Professor Yang Wang, Institute of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
• Professor Qiang Ma, College of Chemistry, Jilin University, Changchun, China
• Professor Lianghai Hu, Jilin University, Changchun, China
• Professor Haiwei Xu, First Affiliated Hospital of Army Medical University (Southwest Hospital), Chongqing, China
• Professor Zhijin Fan, Kunming Medical University, Kunming, China
• Professor Chenghu Hu, Northwestern Polytechnical University, Xi'an, China
• Professor Kewei Zhao, Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
• Professor Min Zhang, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan, China
• Professor Cuiping Zhang, Chinese PLA General Hospital, Beijing, China
• Professor Peiyong Jiang, The Chinese University of Hong Kong, Hong Kong, China
• Professor Mingzhen Zhang, Xi'an Jiaotong University, Xi'an, China
• Professor Lei Lei, Northwest University, Xi'an, China
• Associate Professor Mei Lu, Beijing Institute of Technology, Beijing, China
• Dr. Zhen Yang, Peking University People's Hospital, Beijing, China
• Dr. Kaiyang Wang, Shanghai Sixth People's Hospital, Shanghai, China
• Associate Researcher Lingyan Yang, Guangzhou National Laboratory, Guangzhou, China
• Associate Researcher Judun Zheng, Dermatology Hospital of Southern Medical University, Guangzhou, China
• Associate Researcher Jintao Cheng, Xianghu Laboratory, Hangzhou, China
• Associate Researcher Xiaohong Yang, Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, China
• Assistant Professor Cheng Jiang, The Chinese University of Hong Kong, Shenzhen, China
• Chaoqing Li, School of Medical Laboratory, Hubei University of Chinese Medicine, Wuhan, China
• Changsheng Zhong, Shenzhen Huixin Biomedical Technology Co., Ltd., Shenzhen, China

Opening Ceremony

In June, amid the height of summer, leading academic minds gathered on the banks of the Huangpu River. The conference opening ceremony was hosted by Professor Weiliang Xia, Conference Chair, Vice Dean of the Puyuan Institute for Future Technologies at Shanghai Jiao Tong University, and Executive Editor-in-Chief of EVCNA.

Professor Weiliang Xia Presides over the Conference

At the opening ceremony, Professor Yoke Peng Loh of the National Institutes of Health (NIH), Editor-in-Chief of EVCNA, and Mr. Min Fan, President of OAE Publishing Inc., each delivered opening remarks.

Remarks by Editor-in-Chief Yoke Peng Loh

Editor-in-Chief Yoke Peng Loh extended a warm welcome to all distinguished guests attending the conference and expressed sincere gratitude to colleagues across sectors for their longstanding support for academic exchange and innovation in the field of extracellular vesicles.

Remarks by Mr. Min Fan, President of OAE Publishing Inc.

The speakers expressed the hope that, taking this forum as an important opportunity, they would further promote international academic collaboration and the translation of research findings, and jointly advance extracellular vesicle research to new heights.

Subsequently, Mr. Min Fan provided a comprehensive overview of the company's decade-long development. He reviewed the achievements OAE has made since its establishment in 2015 in journal development, academic platform building, and the development of a global academic ecosystem, and shared the company's development philosophy of serving China's research community and advancing international academic communication.

Plenary Lectures and presentations

The plenary lecture session was co-chaired by Professor Yong Cheng, Professor Shenglin Huang, and Professor Zhangfeng Zhong. The session comprised six presentations, during which distinguished guests engaged in in-depth discussions on a range of cutting-edge topics: EVCNA and translational medicine, gene therapy for Alzheimer's disease, extracellular vesicles and the regulation of organismal homeostasis, the development and clinical translation of microalgae-derived exosomes, quality evaluation of stem cell-derived extracellular vesicles, and immunomodulatory strategies in extracellular vesicle-based therapies. The session comprehensively showcased the latest advances in extracellular vesicle research, spanning basic research to clinical translation, and provided an important academic platform for advancing related technological innovation and industrial development.

Report Topic by Academician Chunhai Fan of Shanghai Jiao Tong University:
"Extracellular Vesicles and Circulating Nucleic Acids and Translational Medicine"

As Honorary Editor-in-Chief of EVCNA, Academician Fan introduced the journal's development history and key milestones, and highly commended its academic quality, publishing philosophy, and future development direction. He has long been dedicated to frontier research in nucleic acid chemistry, bioanalysis, molecular diagnostics, and nanobiotechnology. Fan has also been deeply involved in the development and operation of Shanghai Jiao Tong University's major national science and technology infrastructure for translational medicine, and has made important contributions to advancing translational medicine.

Presentation Topic by Professor Yoke Peng Loh of the NIH:
"Hippocampal delivery of AAV-neurotrophic factor-al reverses cognitive decline, neurodegeneration, and Aβ/tau pathology in Alzheimer's disease mouse models"

Presentation Topic by Professor Yan Jin of Air Force Medical University:
"Extracellular Vesicles and Organismal Homeostasis: Research and Translational Applications"

Professor Min Zhou of Zhejiang University delivered a presentation titled "Exploration of the Development and Clinical Translation of Microalgal Exosomes."

Professor Tao Na of the National Institutes for Food and Drug Control delivered a report titled "Quality Evaluation of Stem Cell-Derived Extracellular Vesicles."

Professor Jan Lötvall of the University of Gothenburg, Sweden, delivered a presentation titled "Targeting the Immune System with EV Therapeutics."

Parallel Sessions

The conference featured four parallel sessions, focusing on cutting-edge directions including the characteristics, mechanisms of action, and health effects of extracellular vesicles; the engineering and application of extracellular vesicles; the development and utilization of extracellular vesicles from different sources; and innovations in research technologies and tools for extracellular vesicles. Participating experts engaged in in-depth exchanges on the latest research findings and key technological breakthroughs in the field, collectively showcasing the latest advances in basic research, technological innovation, and clinical translation of extracellular vesicles. These sessions provided an important platform for promoting interdisciplinary collaborative innovation, advancing high-quality development in the extracellular vesicle field, and facilitating industrial translation.

Parallel Session 1: Extracellular Vesicle Properties, Mechanisms, and Health

Professor Chaohui Huang of the Affiliated Hospital of Jiangnan University delivered a presentation titled "RAB22A Induces Tumor Chemoresistance by Regulating Exosome Secretion."

Professor Hua Xiao of Shanghai Jiao Tong University delivered a presentation titled "Proteomic Research and Functional Analysis of Extracellular Vesicles."

Professor Jingping Liu of West China Hospital, Sichuan University, delivered a presentation titled "Research on the Role of Extracellular Vesicles in Regulating Immunometabolism."

Dr. Kaiyang Wang of Shanghai Sixth People's Hospital delivered a presentation titled "Mechanistic Study of Extracellular Vesicles in Pathological New Bone Formation."

Dr. Zhen Yang of Peking University People's Hospital delivered a presentation titled "3D Cell Culture Enhances Extracellular Vesicle Secretion and Therapeutic Efficacy in Disease Treatment via Actin Depolymerization."

Professor Hui Yu of Shanghai Jiao Tong University delivered a presentation titled "Investigating the Association Between Particle Size and Membrane Proteins in Small Extracellular Vesicles."

Parallel Session II: Engineering and Applications of Extracellular Vesicles

Professor Chenghu Hu of Northwestern Polytechnical University delivered a presentation titled "Engineering and Translational Applications of Extracellular Vesicles."

Professor Cuiping Zhang of the Chinese PLA General Hospital presented "Engineered Exosomes Driving Chronic Wound Repair: Fundamental Breakthroughs and Clinical Translation."

Associate Researcher Lingyan Yang of Guangzhou National Laboratory delivered a presentation titled "Development and Translational Application of Recombinant WNT Extracellular Vesicle Technology for Precision Regenerative Medicine."

Associate Professor Judun Zheng of the Dermatology Hospital of Southern Medical University presented "Engineered Biofunctional Vesicles Promote the Repair of Infected Wounds."

Professor Zhijin Fan of Kunming Medical University delivered a presentation titled "Applications and Mechanistic Studies of Engineered Extracellular Vesicles in the Treatment of Tissue Injury."

Associate Researcher Xiaohong Yang of the Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, presented "Effects and Mechanisms of Engineered Extracellular Vesicles Against MRSA Infection."

Associate Professor Lei Lei of Northwest University delivered a presentation titled "Engineered sEVs for the Treatment of Mucopolysaccharidosis Type II."

Parallel Session III: Applications of Vesicles from Different Sources

Professor Kewei Zhao of the Third Affiliated Hospital of Guangzhou University of Chinese Medicine delivered a presentation titled "Source Tracing and Quality Evaluation of Chinese Herbal Medicine-Derived Vesicles."

Professor Min Zhang of the College of Biomedicine and Health, Huazhong Agricultural University, presented "Gastrodia elata-Derived Extracellular Vesicles Protect the Stressed Mammalian Heart via Cross-Species Mitochondrial Rescue."

Professor Haiwei Xu of the First Affiliated Hospital of Army Medical University, also known as Southwest Hospital, delivered a presentation titled "Applications of Extracellular Vesicles Derived from Stem Cells and Retinal Organoids in Visual Regeneration and Repair."

Professor Mingzhen Zhang of Xi'an Jiaotong University delivered a presentation titled "Research Progress on Traditional Chinese Medicine-Derived Vesicles in the Treatment of Inflammatory Bowel Disease."

Chaoqing Li of the School of Medical Laboratory, Hubei University of Chinese Medicine, delivered a presentation titled "Study on the Efficacy of Coptis Nanovesicles in Infected Wounds."

Researcher Yang Wang of the Institute of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, delivered a presentation titled "Mechanisms of Stem Cell-Derived sEVs in the Prevention and Treatment of Aging-Related Diseases and the Establishment of a Quality Control System."

Associate Researcher Jintao Cheng of Xianghu Laboratory delivered a presentation titled "Construction of an Efficient Delivery Technology System Based on Engineered Bacillus subtilis Outer Vesicles and Its Applications in Health and Skincare."

Parallel Session IV: Innovations in Research Technologies and Tools for Extracellular Vesicles

Professor Xunbin Wei of the Peking University Advanced Institute of Clinical Medicine delivered a presentation titled "In Vivo Optical Flow Cytometric Monitoring for Overcoming Bottlenecks in the Detection of Circulating Tumor Cells and Extracellular Vesicles."

Professor Peiyong Jiang of The Chinese University of Hong Kong delivered a presentation titled "Advances and Clinical Applications of Liquid Biopsy."

Professor Lianghai Hu of Jilin University delivered a presentation titled "High-Throughput Isolation and Multi-Omics Analysis of Tumor-Derived Extracellular Vesicle Subtypes."

Associate Professor Mei Lu of Beijing Institute of Technology delivered a presentation titled "Engineered Exosomes and RNA Delivery."

Assistant Professor Cheng Jiang of The Chinese University of Hong Kong, Shenzhen, delivered a presentation titled "A Vesicle Subpopulation Protein Profiling Chip for the Diagnosis of Degenerative Diseases."

Engineer Changsheng Zhong of Shenzhen Huixin Biomedical Technology Co., Ltd. delivered a presentation titled "Applications of a Multi-Channel Nanoparticle Composite Purification System in Disease Diagnosis and Treatment."

Professor Qiang Ma of Jilin University delivered a presentation titled "Metasurface-Regulated Electrochemiluminescence Strategies and Extracellular Vesicle Detection."

Roundtable Forum

The forum also featured a dedicated roundtable discussion chaired by Professor Weiliang Xia, Vice Dean of the Puyuan Institute for Future Technologies at Shanghai Jiao Tong University. Centered on the theme "Cell Derivatives: Policy Evolution, Clinical Translation, and Future Trends," the session brought together four experts—Professor Qingling Fu of the First Affiliated Hospital of Sun Yat-sen University, Professor Xunbin Wei of the Peking University Advanced Institute of Clinical Medicine, Professor Min Zhou of Zhejiang University, and Professor Tao Na of the National Institutes for Food and Drug Control—for an in-depth dialogue on policy development, clinical translation, and future directions in the field.

Experts shared in-depth insights from the perspectives of policy, clinical practice, and industry on the development of exosomes, microvesicles, and other cell-derived products, particularly regarding regulatory science, clinical translation, and industrialization. The on-site discussions were lively and featured an active exchange of views. Participants agreed that the field is now at a critical stage in its transition from basic research to clinical application, and that policy guidance, standards development, and coordinated industry–academia–research collaboration are urgently needed to advance its development.

Exchanges and Discussions

With the diverse support from three partners, the conference further broadened the scope of academic exchange. A poster display area was also set up to showcase innovative achievements and frontier advances. During the tea breaks, representatives from universities, research institutions, and enterprises engaged in open, multi-level networking and held in-depth discussions on technological development and potential cooperation opportunities. These interactions effectively helped align needs and communication channels among industry, academia, and research, providing strong momentum for deeper collaboration in the future.

EVCNA Editorial Board Meeting

During the forum, the EVCNA Editorial Board held a meeting. Professor Weiliang Xia, Executive Editor-in-Chief for the China Region, joined all Editorial Board members and Young Editorial Board members in reviewing the journal's significant progress in publication output, impact metrics, and international collaboration. They also held in-depth discussions on the journal's next-stage development strategy, building strong consensus for further elevating the journal.

The successful convening of this forum further promoted interdisciplinary integration and high-quality development in extracellular vesicle research and future health, injecting new momentum into the development of an open, collaborative, and innovative academic ecosystem. EVCNA will continue to work closely with colleagues across sectors to build a world-class international platform for academic exchange and to support comprehensive breakthroughs in the extracellular vesicle field, from fundamental research to clinical translation.

Language Editor: Amir Khan
Respectfully Submitted by OAE Publishing Inc.